Back to Search
VICTORINA HOFFMANN, M.D.
M.D.
Internal Medicine Physician
NPI: 1336251693IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A44547(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1985
Research & Publications (20)
Nutrient availability moderates transpiration in Ehrharta calycina.
PMID 18537891·New Phytol·2008
8-other
Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis.
PMID 19327167·BMC Psychiatry·2009
8-other
DC- and RF-GD-OES measurements of adsorbed organic monolayers on copper.
PMID 19680638·Anal Bioanal Chem·2009
8-other
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
PMID 19067709·Br J Dermatol·2009
4-observational
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).
PMID 19217201·Exp Hematol·2009
7-preclinical
Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study.
PMID 19606406·World J Biol Psychiatry·2009
4-observational
A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.
PMID 19535229·Schizophr Res·2009
4-observational
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
PMID 19416259·Br J Dermatol·2009
4-observational
The selenocysteine tRNA STAF-binding region is essential for adequate selenocysteine tRNA status, selenoprotein expression and early age survival of mice.
PMID 18973473·Biochem J·2009
7-preclinical
Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
PMID 18463448·Dermatology·2008
3-trial
Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.
PMID 18512813·Arthritis Rheum·2008
7-preclinical
Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder.
PMID 18793440·BMC Psychiatry·2008
8-other
Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth.
PMID 18373424·Nanomedicine (Lond)·2008
8-other
Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
PMID 18338426·Hum Psychopharmacol·2008
6-review
Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder.
PMID 19209252·Ther Clin Risk Manag·2008
8-other
Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism.
PMID 17996733·Biochem Biophys Res Commun·2008
7-preclinical
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
PMID 17674358·Am J Hematol·2007
7-preclinical
Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
PMID 17785613·Ann Pharmacother·2007
6-review
Skin fragility syndrome in a cat with feline infectious peritonitis and hepatic lipidosis.
PMID 17845626·Vet Dermatol·2007
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1081 MARKET PL STE 200
SAN RAMON, CA 94583 - Phone
- (925) 866-8800
Quick Facts
- NPI
- 1336251693
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile